← Leaderboards
Fabien X Lu
University Of California Davis
$1,006,628
Attributed
$1,006,628
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $414.3K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,006,628 · 8
By mechanism
P51$1,006,628 · 8
Top collaborators
No co-investigators on record.
Most similar at University Of California Davis
Same institution · by research overlap
- Peter A Barry$19,847,796
- Nicholas W Lerche$24,728,788
- Christopher Miller$37,492,368
- Jay V. Solnick$17,687,962
- John P Capitanio$40,214,234
Others in their field
Top investigators on “Aids Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$397,672,739
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$310,476,918
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$247,048,372
- Sharon A Nachman · Johns Hopkins University$210,246,546
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$193,500,790
- Judith S. Currier · University Of California Los Angeles$187,871,648
Research focus
Aids VaccinesAnimal ColonyClinical ResearchHuman Immunodeficiency VirusImmune ResponseImmunotherapyMacaca MulattaNonhuman Therapy EvaluationTransfection /Expression Vector
Grant awards (8)
BETA-CYCLODEXTRAN AS MUCOSAL MICROBICIDE TO PREVENT VAGINAL SIV TRANSMISSION$156,653
P51 · FY2006 · RR · contact PI
HIV VACCINES BASED ON ADENOVIRUS VECTORS$156,653
P51 · FY2006 · RR · contact PI
BETA-CYCLODEXTRAN AS MUCOSAL MICROBICIDE TO PREVENT VAGINAL SIV TRANSMISSION$207,141
P51 · FY2005 · RR
HIV VACCINES BASED ON ADENOVIRUS VECTORS$207,141
P51 · FY2005 · RR
THE IMMUNOGENICITY OF YEAST-BASED HIVAX2.3-P55 VACCINE$14,446
P51 · FY2004 · RR
BETA-CYCLODEXTRAN AS MUCOSAL MICROBICIDE TO PREVENT VAGINAL SIV TRANSMISSION$168,421
P51 · FY2003 · RR
THE IMMUNOGENICITY OF YEAST-BASED HIVAX2.3-P55 VACCINE IN RHESUS MACAQUES$49,527
P51 · FY2003 · RR
MOLECULAR BASIS OF NALT-INDUCED MUCOSAL IMMUNITY TO SIV$46,646
P51 · FY2003 · RR